Etoposide incorporated into camel milk phospholipids liposomes shows increased activity against fibrosarcoma in a mouse model

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Maswadeh, Hamzah M ^a   Aljarbou, Ahmad N ^a   Alorainy, Mohammed S ^a   Alsharidah, Mansour S ^a   Khan, Masood A ^a  

^a QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; BENZO[A]PYRENE; ETOPOSIDE; HEXANE; LIPOSOME; METHANOL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; PHOSPHORIC ACID; ANTINEOPLASTIC AGENT;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CAMEL MILK; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SIZE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; FEMALE; FIBROSARCOMA; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LIMIT OF DETECTION; LIPID COMPOSITION; LIPOPHILICITY; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; SINGLE DRUG DOSE; SURVIVAL; THIN LAYER CHROMATOGRAPHY; ANIMAL; BAGG ALBINO MOUSE; CAMEL; CHEMISTRY; DIFFUSION; DRUG POTENTIATION; MILK; PATHOLOGY; TREATMENT OUTCOME;

MURINAE; MUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMELS; DIFFUSION; DRUG SYNERGISM; ETOPOSIDE; FEMALE; FIBROSARCOMA; LIPOSOMES; MICE; MICE, INBRED BALB C; MILK; PHOSPHOLIPIDS; TREATMENT OUTCOME;

EID: 84925307959     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/743051     Document Type: Article

References (33)

1. J. Jia, F. Zhu, X. Ma, Z. W. Cao, Y. X. Li, and Y. Z. Chen, "Mechanisms of drug combinations: Interaction and network perspectives, " Nature Reviews Drug Discovery, vol. 8, no. 2, pp. 111-128, 2009.
2. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni, "Anthracyclines: molecular advances and pharmacologie developments in antitumor activity and cardiotoxicity, " Pharmacological Reviews, vol. 56, no. 2, pp. 185-229, 2004.
3. J. L. Nitiss, "Targeting DNA topoisomerase II in cancer chemotherapy, " Nature Reviews Cancer, vol. 9, no. 5, pp. 338-350, 2009.
4. D. Wang and S. J. Lippard, "Cellular processing of platinum anticancer drugs, " Nature Reviews Drug Discovery, vol. 4, no. 4, pp. 307-320, 2005.
5. L. Kelland, "The resurgence of platinum-based cancer chemotherapy, " Nature Reviews Cancer, vol. 7, no. 8, pp. 573-584, 2007.
6. A. Martoni, A. Bellucco, N. Canova, and F. Pannuti, "Four-year analysis of platinum and anthracycline combination for ovarian cancer, " Oncology, vol. 46, no. 2, pp. 109-116, 1989.
7. O. S. Nielsen, P. Dombernowsky, H. Mouridsen et al., "Epirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group, " Sarcoma, vol. 4, no. 1-2, pp. 31-35, 2000.
8. J. Tate Thigpen, M. F. Brady, H. D. Homesley et al., "Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study, " Journal of ClinicalOncology, vol. 22, no. 19, pp. 3902-3908, 2004.
9. M. Bigioni, A. Benzo, C. Irrissuto et al., "Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft, " Cancer Chemotherapy and Pharmacology, vol. 62, no. 4, pp. 621-629, 2008.
10. L. Zhao, M. G. Wientjes, and J. L. Au, "Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses, " Clinical Cancer Research, vol. 10, no. 23, pp. 7994-8004, 2004.
11. Y. Pommier, E. Leo, H. Zhang, and C. Marchand, "DNA topoisomerases and their poisoning by anticancer and antibacterial drugs, " Chemistry and Biology, vol. 17, no. 5, pp. 421-433, 2010.
12. D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, "Nanocarriers as an emerging platform for cancer therapy, " Nature Nanotechnology, vol. 2, no. 12, pp. 751-760, 2007.
13. M. E. Davis, Z. Chen, and D. M. Shin, "Nanoparticle therapeutics: an emerging treatment modality for cancer, " Nature Reviews Drug Discovery, vol. 7, no. 9, pp. 771-782, 2008.
14. J. L. Markman, A. Rekechenetskiy, E. Holler, and J. Y. Ljubimova, "Nanomedicine therapeutic approaches to overcome cancer drug resistance, " Advanced Drug Delivery Reviews, vol. 65, no. 13-14, pp. 1866-1879, 2013.
15. A. Candoni, A. Michelutti, E. Simeone, D. Damiani, M. Baccarani, and R. Fanin, "Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins, " European Journal of Haematology, vol. 77, no. 4, pp. 293-299, 2006.
16. T. M. Allen, G. A. Austin, A. Chonn, L. Lin, and K. C. Lee, "Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size, " Biochimica et Biophysica Acta (BBA)-Biomembranes, vol. 1061, no. 1, pp. 56-64, 1991.
17. U. Schroeder, "Nanoparticle technology for delivery of drugs across the blood-brain barrier, " Journal of Pharmaceutical Sciences, vol. 87, no. 11, pp. 1305-1307, 1998.
18. G. Konuspayeva, B. Faye, and G. Loiseau, "The composition of camel milk: a meta-analysis of the literature data, " Journal of Food Composition and Analysis, vol. 22, no. 2, pp. 95-101, 2009.
19. J. M. Evers, R. G. Haverkamp, S. E. Holroyd, G. B. Jameson, D. D. S. Mackenzie, and O. J. McCarthy, "Heterogeneity of milk fat globule membrane structure and composition as observed using fluorescence microscopy techniques, " International Dairy Journal, vol. 18, no. 12, pp. 1081-1089, 2008.
20. S. Gallier, D. Gragson, R. Jiménez-Flores, and D. Everett, "Using confocal laser scanning microscopy to probe the milk fat globule membrane and associated proteins, " Journal of Agricultural and Food Chemistry, vol. 58, no. 7, pp. 4250-4257, 2010.
21. C. Lopez, M.-N. Madec, and R. Jimenez-Flores, "Lipid rafts in the bovine milk fat globule membrane revealed by the lateral segregation of phospholipids and heterogeneous distribution of glycoproteins, " Food Chemistry, vol. 120, no. 1, pp. 22-33, 2010.
22. G. Contarini and M. Povolo, "Phospholipids in milk fat: composition, biological and technological significance, and analytical strategies, " International Journal of Molecular Sciences, vol. 14, no. 2, pp. 2808-2831, 2013.
23. H. Maswadeh, S. Hatziantoniou, C. Demetzos, K. Dimas, A. Georgopoulos, and M. Rallis, "Encapsulation of Vinblastine into new liposome formulations prepared from triticum(wheat germ) lipids and its activity against human leukemic cell lines, " Anticancer Research, vol. 20, no. 6, pp. 4385-4390, 2000.
24. A. Khan, A. A. Khan, V. Dwivedi, M. G. Ahmad, S. Hakeem, and M. Owais, "Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice, "Molecular Medicine, vol. 13, no. 5-6, pp. 266-276, 2007.
25. Z. Farah, "Composition and characteristics of camel milk., " Journal of Dairy Research, vol. 60, no. 4, pp. 603-626, 1993.
26. A. M. S. Gorban and O. M. Izzeldin, "Fatty acids and lipids of camel milk and colostrum, " International Journal of Food Sciences and Nutrition, vol. 52, no. 3, pp. 283-287, 2001.
27. A. A. Korish, "The antidiabetic action of camel milk in experimental type 2 diabetes mellitus: an overview on the changes in incretin hormones, insulin resistance, and inflammatory cytokines, " Hormone and Metabolic Research, vol. 46, no. 6, pp. 404-411, 2014.
28. R. P. Agrawal, P. Tantia, S. Jain, R. Agrawal, and V. Agrawal, "Camel milk: a possible boon for type 1 diabetic patients, " Cellular and Molecular Biology, vol. 59, no. 1, pp. 99-107, 2013.
29. A. A. Korish and M. M. Arafah, "Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease, " BMC Complementary and Alternative Medicine, vol. 13, article 264, 2013.
30. A. A. Alhaider, A. G. M. Abdel Gader, N. Almeshaal, and S. Saraswati, "Camel milk inhibits inflammatory angiogenesis via downregulation of proangiogenic and proinflammatory cytokines in mice, " APMIS, vol. 122, no. 7, pp. 599-607, 2014.
31. H. M. Habib, W. H. Ibrahim, R. Schneider-Stock, and H. M. Hassan, "Camel milk lactoferrin reduces the proliferation of colorectal cancer cells and exerts antioxidant and DNA damage inhibitory activities, " Food Chemistry, vol. 141, no. 1, pp. 148-152, 2013.
32. H. M. Korashy, Z. H. Maayah, A. R. Abd-Allah, A. O. S. El-Kadi, and A. A. Alhaider, "Camel milk triggers apoptotic signaling pathways in human hepatoma HepG2 and breast cancer MCF7 cell lines through transcriptional mechanism, " Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 593195, 9 pages, 2012.
33. T.-L. Hwang, W.-R. Lee, S.-C. Hua, and J.-Y. Fang, "Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas, " Journal of Dermatological Science, vol. 46, no. 1, pp. 11-20, 2007.